Yohimbine, an α2-adrenoceptor antagonist, is used in the treatment of erectile dysfunction. However, it has various side effects such as tachycardia, arrhythmias, hypertension, dizziness, and poisoning. Some of its side effects are also manifested as anxiety, headaches and increased urinary output. Considering the consumption of yohimbine with dietary supplements and its side effects on the human system, the development of a novel, simple and sensitive method for the determination of yohimbine is significant. For this purpose, an electrochemical method was developed on a glassy carbon electrode (GCE) modified with dysprosium oxide (Dy2O3) and graphene nanoplatelets (GRNP). The electrochemical platform (GCE/GRNP@Dy2O3) possessed high electro-active surface area and lower value of charge transfer resistance (Rct). Yohimbine undergoes irreversible oxidation through a diffusion-controlled process. The observation of improved voltammetric behavior and enhanced peak response for yohimbine at GCE/GRNP@Dy2O3 could be attributed to the high synergistic effect between Dy2O3 and GRNP in addition to the increased surface area and electrocatalytic activity. The expected sensing mechanism of GCE/GRNP@Dy2O3 towards yohimbine might be attributed to the surface oxygen vacancies of Dy2O3 which are available on the surface of the nanocomposite. The oxygen atoms can interact with the functional groups of yohimbine and facilitate the oxidation of yohimbine. The peak response and concentration were found to be correlated over a range of 8.0 × 10−9–7.8 × 10−7 M. The GCE/GRNP@Dy2O3 system exhibited a detection limit (LOD) of 5.7 × 10−9 M for yohimbine. Average recovery values of 98.0 %–104.9 % with lower RSD values in yohimbine supplements and 101.0 %–103.0 % in artificial urine confirmed that GCE/GRNP@Dy2O3 provides reliable results for the determination of yohimbine.
Read full abstract